Renalytix plc (RENX) ORD GBP0.0025
Share news, reports & tips
28 July 2021 11:19
(Sharecast News) - Renalytix announced the appointment of Ann Berman to its board on Wednesday, as chair of its audit committee and a member of the nomination committee.
28 June 2021 08:36
(Sharecast News) - Renalytix announced new data demonstrating that its 'KidneyIntelX' product can be effective at monitoring therapeutic response and improvements in kidney health over time, in...
22 June 2021 16:05
(Sharecast News) - Renalytix AI revealed on Tuesday that interim chairman Christopher Mills had disposed of 17,000 ordinary shares in the AIM-listed artificial intelligence firm.
15 June 2021 09:55
(Sharecast News) - Renalytix AI recorded $0.6m (£0.43m) of services revenue in its third quarter, it said on Tuesday, related to work performed for Mount Sinai, and $0.1m of testing revenue.
3 June 2021 10:37
(Sharecast News) - Renalytix AI announced results from a new utility study on Thursday, which confirmed the importance of risk assessment testing in addressing treatment ambiguity in the early stages of...
19 May 2021 10:06
(Sharecast News) - Renalytix AI announced a partnership with Atrium Health, Wake Forest Baptist Health and Wake Forest School of Medicine on Wednesday, to implement an advanced clinical care model designed...
22 April 2021 16:03
(Sharecast News) - Renalytix AI announced on Thursday that the United States government has granted it a 10-year 'Governmentwide Acquisition Contract' (GWAC) to provide 'KidneyIntelX'...
20 April 2021 13:48
(Sharecast News) - Renalytix AI announced the findings of a new study in which the commercially-available 'KidneyIntelX' test accurately predicted the progression of diabetic kidney disease (DKD)...
14 April 2021 09:02
(Sharecast News) - Renalytix AI has entered into an exclusive option agreement with Joslin Diabetes Center for patent filings on additional novel biomarkers in kidney disease, it announced on Wednesday, for...
8 April 2021 08:20
(Sharecast News) - Renalytix AI announced findings presented in a late-breaking presentation at the National Kidney Foundation's 2021 Spring Clinical Meetings on Thursday, titled 'Clinical Utility...
6 April 2021 11:08
(Sharecast News) - Renalytix AI reported on Tuesday that its 'KidneyIntelX' product more accurately predicted progressive kidney function decline and kidney failure in a multi-centre, diverse...
15 March 2021 08:55
(Sharecast News) - Artificial intelligence (AI) diagnostics company Renalytix AI updated the market on the establishment of the 'Medicare Coverage of Innovative Technology' (MCIT) pathway on...
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.